Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

How Long Does It Take To Change A Name?

Executive Summary

Three-month timeframe for nonproprietary name changes of two botulinum toxin products is unlikely to be replicated for the dozens of currently licensed biologics subject to FDA’s requirement for distinguishable suffixes.

You may also be interested in...



Trump Order Reducing Regulation Might Imperil FDA Good Guidance Practices

Executive order mandating two existing regulations be eliminated for every new one issued includes guidances, raising questions about how FDA will communicate with industry going forward.

Biologic Product Naming: US FDA Sticks With Suffixes ‘Devoid Of Meaning’

Final guidance adds new factors for biosimilar and innovative sponsors to consider in developing distinguishable suffixes for nonproprietary names but FDA is unswayed by calls for meaningful suffixes derived from license holder’s name; timing of retrospective application to previously approved products remains in question.

FDA Biosimilar Naming Policy Takes Middle-Of-The-Road Approach

Most biologics will have random four-letter suffix added to nonproprietary name, but FDA asks a number of questions about potential alternatives.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

GB002318

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel